510(k) · Cleared
Recalled · Class II · 2026Greiner Vacuette Blood Collection Tube W/Lithium Heparin & Gel Separator
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Greiner America, Inc. · JKA Tubes, Vials, Systems, Serum Separators, Blood Collection
Cleared on Aug 30, 1996 as substantially equivalent to K944566 (Bd Becton Dickinson Vacutainer Systems Preanalytic, 1994) after a 182-day review. Its family tree reaches back 1 generation to 1994. 1 later device descends from it. It has been recalled 5 times.
- Decided
- Aug 30, 1996
- Review
- 182 days
- Class
- Class II
- Product code
- JKA
- Recalls
- 5
- Predicates
- 1
Its longest line of descent runs back 1 generation to K944566 (1994). 1 later device descends from it, 1 citing it directly.
- Root · 1 generation backK944566 Vacutainer Brand Plus Sodium Heparin TubeBd Becton Dickinson Vacutainer Systems Preanalytic · 1994 · Recalled
- This deviceK960857 Greiner Vacuette Blood Collection Tube W/Lithium Heparin & Gel…Greiner America, Inc. · 1996
- Descendant · cites it directly · 0 of its ownK011699 Vacuette Evacuated Blood Collection TubesGreiner Bio-One Vacuette North America · 2001
Most influential descendants
Showing 1 of 1 · See all- K011699Vacuette Evacuated Blood Collection TubesGreiner Bio-One Vacuette North America · 2001 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K944566 | Vacutainer Brand Plus Sodium Heparin Tube | Bd Becton Dickinson Vacutainer Systems Preanalytic | 1994 | 2 |
| 0 (this device) | K960857 | Greiner Vacuette Blood Collection Tube W/Lithium Heparin & Gel Separator | Greiner America, Inc. | 1996 | — |
| +1 | K011699 | Vacuette Evacuated Blood Collection Tubes | Greiner Bio-One Vacuette North America | 2001 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2001 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in JKA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new JKA device
- #1 K200027 Blood Collection Needle with/without Holder…score 15.6 · 3 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K944566 | Vacutainer Brand Plus Sodium Heparin TubeSummary page 1…g blood plasma from the cellular components of blood. Greiner is claiming substantial equivalence to Becton Dickinson's Vacutainer® brand lithium heparin additive tube (K944566). Both blood collection tubes have the same intended use and contain the same stopper material, additive and separator. The tube… | 1994 |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K011699 | Vacuette Evacuated Blood Collection Tubes | 2001 | 0 |
Has anything in its family been recalled? (0 Class I)
Recalls of this device
| Date | Class | Recall | Root cause | Reason |
|---|---|---|---|---|
| Jul 29, 2026 | Class II | Z-0200-2027 | Nonconforming Material/Component | Lot B26043FM may include EDTA contamination which introduces potassium while chelating calcium in patient samples, leading to falsely elevated potassium (K+) and falsely decreased calcium (Ca++) results which have the potential to cause… |
| Dec 9, 2021 | Class II | Z-0502-2022 | Under Investigation by firm | Some of the blood collection tubes show clotting due to variation of Lithium Heparin. |
| Dec 14, 2011 | Not classified | Z-1081-2012 | Material/Component Contamination | The lithium heparin tubes may have a contamination with EDTA potassium. |
| Aug 25, 2010 | Not classified | Z-0623-2011 | Other | Lithium heparin solution was contaminated by EDTA K (potassium) solution due to an operator error and a misinterpretation of a test result. Contaminated tubes will produce inaccurate test results. |
| Jul 29, 2008 | Not classified | Z-0215-2009 | Labeling mix-ups | Labeling Error: Incorrect tube label reads "Z Serum Clot Activator" instead of "LH Lithium Heparin" tube. All other information on the tube label including color coding of tube was correct. Case and rack label information showed the… |
No ancestor or descendant has a Class I recall.
What does this lineage say?
How does its category compare?
All JKA devicesJKA Tubes, Vials, Systems, Serum Separators, Blood Collection: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · JKA
7in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · JKA
115in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · JKA
13in 2025
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · JKA
6,089in 2025
MAUDE reports naming product code JKA, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 4 | 281 | 3 | 73 |
| 2008 | 2 | — | 3 | 78 |
| 2009 | 2 | — | 3 | 42 |
| 2010 | 4 | 28 | 4 | 37 |
| 2011 | 0 | — | 14 | 67 |
| 2012 | 1 | — | 2 | 54 |
| 2013 | 3 | 244 | 1 | 33 |
| 2014 | 1 | — | 1 | 68 |
| 2015 | 1 | — | 6 | 41 |
| 2016 | 4 | 116 | 1 | 65 |
| 2017 | 2 | — | 2 | 2,039 |
| 2018 | 1 | — | 2 | 9,731 |
| 2019 | 6 | 181 | 9 | 6,469 |
| 2020 | 6 | 181 | 0 | 3,774 |
| 2021 | 4 | 217 | 3 | 3,610 |
| 2022 | 9 | 164 | 2 | 3,375 |
| 2023 | 17 | 189 | 2 | 4,400 |
| 2024 | 6 | 240 | 0 | 4,609 |
| 2025 | 7 | 115 | 13 | 6,089 |
| 2026 | 8 | 250 | 1 | — |
What is it indicated for?
The product is intended for use in holding and separating blood plasma from the cellular components of blood.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K960857 · printed Nov 4, 2026
Cite this page
510(k) Report. “K960857: Greiner Vacuette Blood Collection Tube W/Lithium Heparin & Gel Separator.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K960857
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026